| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
61,650,000 |
| Market
Cap: |
192.96(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.08 - $7.57 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.1 |
| Insider 3/6 Months : 6.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Omeros is a commercial-stage biopharmaceutical company. Co. is focused on discovering, developing and commercializing small-molecule and protein therapeutics for larger-market as well as orphan indications targeting immunologic diseases. Co.'s drug candidate narsoplimab is the subject of a biologics license application pending before the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Co. has various late-stage clinical development programs in its pipeline, which are focused on: complement-mediated disorders, including immunoglobulin A nephropathy, atypical hemolytic uremic syndrome and COVID-19.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
25,000 |
25,000 |
25,000 |
| Total Buy Value |
$0 |
$40,500 |
$40,500 |
$40,500 |
| Total People Bought |
0 |
2 |
2 |
2 |
| Total Buy Transactions |
0 |
2 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
10,000 |
10,000 |
| Total Sell Value |
$0 |
$0 |
$64,950 |
$64,950 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Aspiri Ray |
Director |
– • – |
2010-06-30 |
4 |
OE |
$0.98 |
$15,000 |
D/D |
15,306 |
15,306 |
|
- |
|
| Tripet Jean-Philippe |
Director |
– • – |
2009-10-13 |
4 |
A |
$0.00 |
$0 |
I/I |
489,568 |
493,102 |
|
- |
|
| Demopulos Peter A Md |
Director |
– • – |
2009-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
57,144 |
99,421 |
|
- |
|
| Hood Leroy E. Md Phd |
Director |
– • – |
2009-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
28,880 |
28,880 |
|
- |
|
| Cable Thomas J. |
Director |
– • – |
2009-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
56,792 |
76,108 |
|
- |
|
| Aspiri Ray |
Director |
– • – |
2009-10-13 |
4 |
A |
$0.00 |
$0 |
I/I |
119,902 |
146,872 |
|
- |
|
| Tripet Jean-Philippe |
Director |
– • – |
2009-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,534 |
|
- |
|
| Kelbon Marcia S. |
VP, Patent & Gen Cnsl, Sec.Off |
• – – |
2009-10-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
107,147 |
|
- |
|
| Demopulos Peter A Md |
Director |
– • – |
2009-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
164,382 |
|
- |
|
| Demopulos Peter A Md |
Director |
– • – |
2009-10-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,277 |
|
- |
|
| Demopulos Gregory A Md |
See General RemarksOfficer |
• • • |
2009-10-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,475,280 |
|
- |
|
| Cable Thomas J. |
Director |
– • – |
2009-10-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,316 |
|
- |
|
| Aspiri Ray |
Director |
– • – |
2009-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
26,970 |
|
- |
|
163 Records found
|
|
Page 7 of 7 |
|
|
0.02 (0.63%) 
